| Literature DB >> 35917608 |
Wissal Skhiri1, Marwa Moussaoui2, Jamal Saad2, Mohamed Maatouk3, Asma Chaouch3, Ines Mazhoud2.
Abstract
INTRODUCTION: Intramural duodenal hematoma is a rare entity, often secondary to traumatic origin, but more rarely spontaneous due to blood flow disorders, especially in the context of anticoagulant therapy. CASEEntities:
Keywords: Acute pancreatitis; Case report; Intramural duodenal hematoma; Review of the literature
Year: 2022 PMID: 35917608 PMCID: PMC9403202 DOI: 10.1016/j.ijscr.2022.107424
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1(A,B): CT coronal reconstructions without contrast injection showing a regular circumferential parietal thickening spontaneously hyperdense of the D2, D3 portions of the duodenum (arrowheads), swollen pancreas (arrow) with densification of the mesenteric fat around (star).
Fig. 2CT axial reconstruction without contrast injection showing a regular circumferential parietal thickening spontaneously hyperdense of the D2, D3 portions of the duodenum (arrowheads) with densification of the surrounding mesenteric fat (star).
Fig. 3(A): CT coronal reconstruction with contrast injection showing a regular circumferential parietal thickening of the D2, D3 portions of the duodenum (arrowheads), swollen pancreas (arrow) with densification of the mesenteric fat around (star), B: axial reconstruction with contrast injection showing a swollen pancreas (arrow).
Fig. 4CT coronal reconstructions with contrast injection showing a regression of the regular parietal thickening of the D2, D3 portions of the duodenum and the densification of the mesenteric fat around (arrowheads), the pancreas returns to its normal size (star).
Published cases of pancreatitis associated with intramural duodenal hematoma.
| Reference | Year | Age/sex | Medical history | Chronic alcoholism | Cause of IHD | Treatment | Type(*) | |
|---|---|---|---|---|---|---|---|---|
| 19 | Present case | 66F | AF | No | AC | Med | A | |
| 18 | Figueiredo and al | 2019 | 55 M | None | Yes | AP | Med | B |
| 17 | ELGHALI and al | 2019 | 68 M | D, AF | No | AC | Med | A |
| 16 | ELGHALI and al | 2019 | 72F | MVR | No | AC | Med | A |
| 15 | ELGHALI and al | 2019 | 54F | MVR | No | AC | Med | A |
| 14 | OFORI and al | 2018 | 83 M | H, D, AZ | No | Inj | Med | A |
| 13 | OLIVIA and al | 2017 | 43 M | AP | Yes | AP | OP | C |
| 12 | Eurboonyanun and al | 2016 | 27 M | None | Yes | AP | Med | B |
| 11 | Chang and al | 2015 | 43 M | None | Yes | AP | Med | B |
| 10 | Elmoghaz and al | 2015 | 31 M | None | Yes | AP-dd | OP | B |
| 9 | Gharbi and al | 2014 | 67 M | MVR,H, epilepsy | NO | AC | Med | A |
| 8 | Khurana and al | 2014 | 73 F | DVT | No | AC/ADK p/PA | Op | B |
| 7 | Veloso and al | 2013 | 64 M | MI | Yes | AC | Med | A |
| 6 | Lee CY and al | 2013 | 47 M | D-HVB | No | AP (dengue) | Med | B |
| 5 | Dinis Silva and al | 2012 | 80 M | AF/arthrosis | No | Inj | Med | A |
| 4 | Goyal and al | 2012 | 29 M | None | Yes | – | Med | A |
| 3 | Young Lee and al | 2012 | 55 M | AP | Yes | AP | End | B |
| 2 | Fukunaga and al | 2011 | 49 M | None | Yes | AP | OP | B |
| 1 | Neuzillet and al | 2011 | 62 M | AP | Yes | AP | OP | C |
AP: acute pancreatitis; MVR: mitral valve replacement; AF: atrial fibrillation, MI: myocardial infarction, inj: therapeutic injection for bleeding peptic ulcer, dd: duodenal diverticulum, DVT: deep vein thrombosis, Op: Operation, Endo: Endoscopy, ADK p: pancreatic adenocarcinoma, H: high blood pressure, D: diabetes, AZ: Alzheimer's disease; Med: medical treatment, HVB: viral hepatitis B, AC: anticoagulation.
(*): A classification made by Schiozawa and al, interesting non traumatic IDH associated with pancreatic diseases: A: acute pancreatitis due to duodenal papilla obstruction by hematoma; B: hematoma formation due to vascular disruption by pancreatic enzymes released during acute pancreatitis; and C: hematoma formation due to vascular disruption by pancreatic enzymes released during chronic pancreatitis or its acute exacerbation.